S2M — S2Medical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK4.72m
- SEK3.81m
- SEK14.36m
Brief: S2Medical Plans Rights Issue To Raise SEK 2.9 Mln
Brief: S2medical H2 Net Sales At SEK 7.5 Mln
Brief: S2medical Signs Exclusive Distribution Agreement In UAE
Brief: S2Medical Validates European Patent For AMP Technology In 18 Countries
Brief: S2Medical Carries Out Directed Issue To External Partner
Brief: S2Medical H1 Oper Loss SEK 0.5 Mln
Brief: S2medical Signs Exclusive Distribution Agreement With Protech
Brief: S2Medical Granted Patent Protection For IvaQ In South Africa
Brief: S2medical H2 Oper Loss Narrows To SEK 2.4 Mln
Brief: S2Medical Signs Exclusive Distribution Agreement For Biopad In Phillipines
Brief: S2medical Gets US Patent Approval For 'Plantaricin NC8 Alpha Beta'
Brief: S2Medical Provides Preliminary Outcome Of Rights Issue
Brief: S2medical Secures Possibility Of Freezing Assets
Brief: S2medical Starts Commercialisation Of Cosmetic Formulation
Brief: S2Medical To Carry Out Rights Issue
Brief: S2medical Q2 Revenue Up At SEK 2.9 Million
Brief: Epiprotect® Demonstrates Significantly Lower Infection Risk In Major Pediatric Study
Brief: S2medical Says Co Is Debt Free
Brief: S2medical Q1 Operating Result Turns To Profit Of SEK 0.8 Mln